Physician
Black Hills Pediatrics, LLP
Black Hills Pediatrics, LLP was paid $9.66M by Medicaid between Jan 2018 and Dec 2024, across 89 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.
33Billing provider infoBLACK HILLS PEDIATRICS, LLP
RAPID CITY, SD 57701
RAPID CITY, SD 57701
33aNPI1639229727assigned 01/11/2007
33bProvider typePediatrics Physician
28Total paid$9.66M
24GClaims288,877
24DCodes billed89
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in South Dakota
Rank by total paid#1 of 6
Median peer was paid$765K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 46,456 | $1.84M | |
| 2019 | 44,415 | $1.58M | |
| 2020 | 28,402 | $999K | |
| 2021 | 42,675 | $1.43M | |
| 2022 | 45,636 | $1.42M | |
| 2023 | 42,474 | $1.09M | |
| 2024incomplete | 38,819 | $1.30M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 51,584 | 39,983 | $2.25M |
| 90378 | 10% | 493 | 284 | $1.01M | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 7.2% | 2,073 | 1,977 | $698K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 7.1% | 10,557 | 9,642 | $687K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.0% | 8,485 | 8,254 | $575K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.3% | 11,472 | 10,381 | $412K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 3.4% | 1,137 | 1,049 | $333K |
| 99460 | 3.4% | 4,119 | 3,862 | $326K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.4% | 4,546 | 4,162 | $325K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 3.1% | 4,495 | 4,340 | $303K |
| 99238 | Hospital discharge day management, 30 minutes or less | 3.1% | 5,424 | 4,916 | $297K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 2.7% | 14,577 | 14,069 | $263K |
77 more codes
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.6% | 2,708 | $252K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.5% | 24,019 | $243K |
| 54150 | 2.0% | 1,387 | $192K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.7% | 2,390 | $162K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 5,103 | $147K |
| 99232 | Hospital visit by a doctor, follow-up day | 1.2% | 2,497 | $113K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 1,062 | $90K |
| 87581 | <1% | 2,071 | $86K | |
| 99462 | <1% | 2,043 | $68K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 741 | $64K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,310 | $62K |
| 90474 | <1% | 6,128 | $60K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,441 | $59K |
| 87486 | <1% | 1,438 | $58K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 496 | $46K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,159 | $40K |
| 83655 | <1% | 3,045 | $38K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,770 | $32K |
| W0037 | <1% | 10,767 | $32K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 305 | $29K |
| 85027 | <1% | 4,076 | $27K | |
| 74018 | <1% | 1,701 | $27K | |
| 87634 | <1% | 421 | $26K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 344 | $23K |
| 93325 | <1% | 727 | $19K | |
| 36416 | <1% | 11,141 | $17K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,847 | $15K |
| 99381 | <1% | 140 | $14K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,240 | $11K |
| 82247 | <1% | 2,111 | $11K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,027 | $10K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,384 | $9K |
| 93320 | <1% | 305 | $9K | |
| 99188 | <1% | 373 | $9K | |
| 17110 | <1% | 115 | $9K | |
| 80053 | Comprehensive metabolic panel | <1% | 899 | $8K |
| 81001 | <1% | 2,143 | $7K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 711 | $6K |
| 99383 | <1% | 57 | $5K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 383 | $5K |
| 99000 | <1% | 3,021 | $4K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 105 | $4K |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 1,139 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 497 | $3K |
| 90670 | <1% | 7,247 | $3K | |
| 90677 | <1% | 1,158 | $3K | |
| 90651 | <1% | 1,882 | $3K | |
| 80061 | Lipid panel | <1% | 158 | $2K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 50 | $2K |
| 99217 | <1% | 26 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 20 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 477 | $1K |
| 86140 | <1% | 180 | $783.51 | |
| 90686 | <1% | 6,450 | $759.19 | |
| 90710 | <1% | 1,498 | $576.24 | |
| 90633 | <1% | 4,018 | $574.24 | |
| 90685 | <1% | 1,721 | $489.77 | |
| 96161 | <1% | 95 | $245.91 | |
| 90620 | <1% | 472 | $160.75 | |
| 90696 | <1% | 1,413 | $152.28 | |
| 90734 | <1% | 1,444 | $131.42 | |
| 90715 | <1% | 862 | $120.56 | |
| 86308 | <1% | 17 | $83.26 | |
| 81003 | <1% | 30 | $81.72 | |
| 96127 | <1% | 14 | $72.28 | |
| 90688 | <1% | 241 | $27.11 | |
| 90687 | <1% | 216 | $14.00 | |
| 90716 | 0% | 2,037 | $0.00 | |
| 90744 | 0% | 1,595 | $0.00 | |
| 90680 | 0% | 6,232 | $0.00 | |
| 90698 | 0% | 2,286 | $0.00 | |
| 90723 | 0% | 4,400 | $0.00 | |
| 90381 | 0% | 24 | $0.00 | |
| 90656 | 0% | 899 | $0.00 | |
| 90707 | 0% | 2,007 | $0.00 | |
| 90648 | 0% | 6,146 | $0.00 | |
| 90700 | 0% | 1,813 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHASS, DEAN (BUSINESS ADMINISTRATOR)